Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: Beyond biomarker discovery

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that has heterogeneous clinical manifestation with diverse patterns of organ involvement, autoantibody profiles and varying degrees of severity of disease. Research and clinical experience indicate that different subtypes of SLE patients will likely benefit from more tailored treatment regimes, but we currently lack a fast and objective test with high enough sensitivity to enable us to perform such sub‐grouping for clinical use. In this article, we review how proteomic technologies could be used as such an objective test. In particular, we extensively review many leukocyte surface markers that are known to have an association with the pathogenesis of SLE, and we discuss how these markers can be used in the further development of a novel SLE‐specific antibody leukocyte capture microarray. In addition, we review some bioinformatics challenges and current methods for using the data generated by these cell‐capture microarrays in clinical use. In a broader context, we hope our experience in developing a disease specific cell‐capture microarray for clinical application can be a guide to other proteomic practitioners who intend to extend their technologies to develop clinical diagnostic and prognostic tests for complex diseases.

[1]  P. Limburg,et al.  Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus , 2001, Annals of the rheumatic diseases.

[2]  E. Milner,et al.  A New Population of Cells Lacking Expression of CD27 Represents a Notable Component of the B Cell Memory Compartment in Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[3]  N. Knowlton,et al.  Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. , 2008, Arthritis and rheumatism.

[4]  Mike Scott,et al.  Classification of AML using a monoclonal antibody microarray. , 2006, Methods in molecular medicine.

[5]  Andrew J. Bulpitt,et al.  A Primer on Learning in Bayesian Networks for Computational Biology , 2007, PLoS Comput. Biol..

[6]  F. Braet,et al.  Using Antibody Arrays to Detect Microparticles from Acute Coronary Syndrome Patients Based on Cluster of Differentiation (CD) Antigen Expression* , 2009, Molecular & Cellular Proteomics.

[7]  Andreas Radbruch,et al.  HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[8]  Baowen Xu,et al.  Application of Metamorphic Testing to Supervised Classifiers , 2009, 2009 Ninth International Conference on Quality Software.

[9]  R. Christopherson,et al.  Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. , 2001, Cancer research.

[10]  S. Hanash,et al.  Mining the plasma proteome for cancer biomarkers , 2008, Nature.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Rantapää-Dahlqvist,et al.  Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[13]  P. Macdonald,et al.  Increases in leukocyte cluster of differentiation antigen expression during cardiopulmonary bypass in patients undergoing heart transplantation , 2004, Proteomics.

[14]  Wentian Li,et al.  Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.

[15]  Finn V. Jensen,et al.  Bayesian Networks and Decision Graphs , 2001, Statistics for Engineering and Information Science.

[16]  X. Mariette,et al.  Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[17]  A. Perl,et al.  Abnormal T cell signal transduction in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[18]  Javier Martín,et al.  Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[19]  Pedro Larrañaga,et al.  A review of feature selection techniques in bioinformatics , 2007, Bioinform..

[20]  YH Lee,et al.  Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis , 2009, Lupus.

[21]  Huai Liu,et al.  An innovative approach for testing bioinformatics programs using metamorphic testing , 2009, BMC Bioinformatics.

[22]  Chang H. Kim.  Migration and function of Th17 cells. , 2009, Inflammation & allergy drug targets.

[23]  Sharon L R Kardia,et al.  Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. , 2003, The American journal of pathology.

[24]  D. Koller,et al.  From signatures to models: understanding cancer using microarrays , 2005, Nature Genetics.

[25]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[26]  C. Mohan,et al.  Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. , 1999, Journal of immunology.

[27]  D. Ye,et al.  Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis , 2009, Molecular Biology Reports.

[28]  J. Welsh,et al.  Molecular classification of human carcinomas by use of gene expression signatures. , 2001, Cancer research.

[29]  Ming Li,et al.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[30]  F. Braet,et al.  Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases , 2008 .

[31]  Blaise Hanczar,et al.  Classification with reject option in gene expression data , 2008, Bioinform..

[32]  F. Braet,et al.  Stable and unstable angina: Identifying novel markers on circulating leukocytes , 2008, Proteomics. Clinical applications.

[33]  Michael A Charleston,et al.  Inferring differential leukocyte activity from antibody microarrays using a latent variable model. , 2008, Genome informatics. International Conference on Genome Informatics.

[34]  C. Turtle,et al.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus , 2009, The Journal of experimental medicine.

[35]  B. Diamond,et al.  Selective dysregulation of the FcγIIB receptor on memory B cells in SLE , 2006, The Journal of Experimental Medicine.

[36]  Jennifer E. Van Eyk,et al.  Clinical proteomics : from diagnosis to therapy , 2007 .

[37]  Mike Scott,et al.  Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray , 2006, British journal of haematology.

[38]  Xinrui Li,et al.  Fcγ receptors: structure, function and role as genetic risk factors in SLE , 2009, Genes and Immunity.

[39]  D. Tarlinton.  Faculty Opinions recommendation of Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. , 2006 .

[40]  Kai-Chung Hsueh,et al.  Efficacy of Autoantigen Microarrays for Detecting Autoantibodies in Patients with Systemic Lupus Erythematosus , 2005 .

[41]  R. Christopherson,et al.  Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. , 2005, Journal of immunological methods.

[42]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[43]  R. Eddy,et al.  Genomic Organization and Chromosomal Localization of the Gene Encoding Human P-selectin Glycoprotein Ligand (*) , 1995, The Journal of Biological Chemistry.

[44]  W. Mccune,et al.  Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.

[45]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[46]  M. Tewari,et al.  The Clinical Applications of a Systems Approach , 2006, PLoS medicine.

[47]  M. Cook,et al.  Follicular helper T cells are required for systemic autoimmunity , 2009, The Journal of experimental medicine.

[48]  D. Choubey,et al.  Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice , 2003, The Journal of experimental medicine.

[49]  James Bailey,et al.  A voting approach to identify a small number of highly predictive genes using multiple classifiers , 2009, BMC Bioinformatics.

[50]  H. Nossent,et al.  B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time , 2006, Lupus.

[51]  C. Berek,et al.  Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[52]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Akira,et al.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.

[54]  P. Limburg,et al.  Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity , 2001, Lupus.

[55]  P. Lipsky,et al.  Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. , 2008, Arthritis and rheumatism.

[56]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[57]  P. Gaffney,et al.  Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE , 2009, Genes and Immunity.

[58]  Dieter Stoll,et al.  A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.

[59]  C. Bao,et al.  Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients , 2008, Arthritis research & therapy.

[60]  P. Gregersen,et al.  The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.

[61]  V. Pascual,et al.  Autoimmunity through cytokine-induced dendritic cell activation. , 2004, Immunity.

[62]  Jin-Young Choi,et al.  Intrinsic T Cell Defects in Systemic Autoimmunity , 2003, Annals of the New York Academy of Sciences.

[63]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[64]  J. Ravetch,et al.  The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells , 2005, Nature Immunology.

[65]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[66]  Marta E Alarcón-Riquelme,et al.  The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. , 2004, Arthritis and rheumatism.

[67]  Lingyun Sun,et al.  Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus , 2007, Clinical Rheumatology.

[68]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[69]  Á. Carracedo,et al.  Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. , 2004, Arthritis and rheumatism.

[70]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[71]  M. Abdel-Rahim,et al.  Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis , 2007, Clinical Rheumatology.

[72]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[73]  A. Voss,et al.  A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients , 2004, Lupus.

[74]  L-L Fung,et al.  Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus , 2004, Scandinavian journal of immunology.

[75]  R. Huang,et al.  Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. , 2001, Analytical biochemistry.

[76]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[78]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[79]  A. Butte,et al.  Multiplexed protein array platforms for analysis of autoimmune diseases. , 2006, Annual review of immunology.

[80]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[81]  C. Lam,et al.  Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. , 2005, Rheumatology.

[82]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[83]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[84]  D. Isenberg,et al.  Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers , 2002, Lupus.